Effect of bilateral parasternal subpectoral interfascial block (PSIB) on fast track recovery after pediatric cardiac surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200058835

Enrollment

Unknown

Registered

2022-04-17

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

PSIB group:Bilateral PSIB blocks with ropivacaine

Control group:None

Eligibility

Sex/Gender

All

Age

0.5 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 0.5-6 years; 2. Ventricular septal defect repair; 3. Subjects of ASA grade I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with LVEF < 35%; 2. Patients who had allergies to ropivacaine; 3. Patients with the chest deformities; 4. Patients with local infection of the skin at the site of needle puncture; 5. Patients with hepatic and renal insufficiency; 6. Patients with emergency operation; 7. Patients who underwent second thoracotomy.

Design outcomes

Primary

Measure	Time frame
Modified Objective Pain Score (MOPS);	—

Secondary

Measure	Time frame
The total dose of fentanyl in the first postoperative 12 h;Time to extubation;ICU length of stay;Hospitalization days after postoperative;Complications of nerve block;	—

Countries

China

Contacts

Public ContactYin Fang

The First Affiliated Hospital of Nanjing Medical University

yitianfang@sina.cn+86 19895858586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026